Spinal cord stimulators market is expected to grow at a CAGR of 10.2% during the forecast period. The market is driven by rising demand for instruments that are used for treating chronic pain and failed back syndrome. Various Spinal cord stimulators are getting approved by FDA which creates enormous opportunities for the market. For instance, in January 2018, the US FDA approved Nevro Corporation’s Senza II for chronic pain treatment. The company again reached FDA’s approval for Algovita spinal cord stimulation device in June 2019.
To Request a Sample of our Report on Spinal Cord Stimulators Market: https://www.omrglobal.com/request-sample/spinal-cord-stimulators-market
Moreover, several product launches were reported over the years. for instance, Boston Scientific Corp. launched Precision Plus spinal cord stimulator system. The system enables to control the amount of current that are delivered to every contact, like it’s another product named Precision Spectra. It contains and 16 dedicated power sources and 16 contacts that enables to exactly target pain with increments of 0.04 mm.
(Get 15% Discount on Buying this Report)
A full Report of Spinal Cord Stimulators Market is Available at: https://www.omrglobal.com/industry-reports/spinal-cord-stimulators-market
Global Spinal Cord Stimulators Market Segmentation
By Application
· Failed Back Syndrome
· Complex Regional Pain Syndrome
· Degenerative Disk Disease
· Others
By End-User
· Hospitals and Clinics
· Research Institutes
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
